Why are men less affected by osteoporosis than women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Why Men Are Less Affected by Osteoporosis

Men achieve higher peak bone mass than women, resulting in bigger and stronger bones throughout life, which provides greater structural protection against fractures. 1

Fundamental Skeletal Advantages in Men

Men possess several intrinsic skeletal advantages that reduce their osteoporosis burden:

Peak Bone Mass and Bone Size

  • Men achieve higher peak bone mass than women because they have bigger bones, not because peak bone mineral density (BMD) is higher 1, 2
  • The larger cross-sectional surface area of male bones provides greater structural strength and resistance to fracture 2
  • This size advantage persists throughout life, creating a protective buffer against age-related bone loss 1

Differential Bone Loss Patterns

Men and women lose bone differently with aging, which fundamentally explains the sex disparity:

  • Men experience trabecular bone loss primarily through decreased trabecular thickness while maintaining trabecular connectivity 1
  • Women lose trabecular connectivity entirely, which is far more detrimental to bone strength 1
  • Men have less cortical bone loss because endocortical resorption is reduced and periosteal bone formation is greater 2
  • Periosteal appositional growth in men compensates for endocortical resorption by maintaining the bending strength of bone 2

Hormonal Differences

  • Men do not experience an abrupt cessation of sex hormone production comparable to menopause in women 3
  • While testosterone levels decline gradually with age, there is no "andropause" causing accelerated bone loss like the menopausal transition in women 3
  • Both bioavailable androgens and estrogens (from peripheral aromatization) contribute to maintaining bone mass in men 4

Clinical Impact: The Fracture Gap

Despite these protective factors, the sex difference in fracture risk narrows substantially with advancing age:

  • Hip fracture incidence ratio (men:women) decreases from 1:4.5 at age 60-69 years to 1:1.5 at age 70-79 years 1
  • Forearm fractures remain approximately 4 times higher in women than men (0.4% versus 0.1% of the population at risk) 1
  • One in five men over age 50 will still experience an osteoporotic fracture in their remaining lifetime 1

Critical Caveat: Higher Mortality in Men

While men have lower fracture incidence, when men do fracture, they face substantially higher mortality than women—inpatient mortality after hip fracture is 10.2% in men versus 4.7% in women, and 1-year mortality is 37.5% versus 28.2% 1. This excess mortality is attributed to greater comorbidity burden and infection rates 1.

The Underdiagnosis Problem

Men's relative protection from osteoporosis has paradoxically led to systematic underdiagnosis and undertreatment 1. The lower prevalence creates a false sense of security among clinicians, despite the substantial and increasing global burden of male osteoporosis 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Osteoporosis in men.

Bailliere's clinical rheumatology, 1997

Research

Osteoporosis in older men: recent advances in pathophysiology and treatment.

Best practice & research. Clinical endocrinology & metabolism, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.